Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients

CompletedOBSERVATIONAL
Enrollment

577

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 15, 2017

Study Completion Date

February 15, 2017

Conditions
Opportunistic Infections
Trial Locations (15)

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

28034

Hospital Ramón y Cajal, Madrid

28041

Hospital Universitario 12 Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

29010

Hospital Carlos Haya, Málaga

30120

Hospital Universitario Virgen de la Arrixaca, El Palmar

35010

Hospital Dr. Negrín, Las Palmas de Gran Canaria

39008

Hospital Marqués de Valdecilla, Santander

45071

Hospital Virgen de la Salud, Toledo

46017

Hospital Universitario Doctor Peset, Valencia

50009

Hospital Miguel Servet, Zaragoza

07120

Hospital Son Espases, Palma de Mallorca

08003

Hospital del Mar, Barcelona

08035

Hospital Vall d´Hebrón, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
collaborator

Roche Farma, S.A

INDUSTRY

lead

Sociedad Española de Trasplante

OTHER

NCT03083756 - Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients | Biotech Hunter | Biotech Hunter